LBA-7 Encorafenib plus cetuximab with or without binimetinib for BRAFV600E metastatic colorectal cancer (mCRC): Relationship between carcinoembryonic antigen (CEA) and clinical outcomes from BEACON CRC

Authors :: Ashwin Gollerkeri
Fortunato Ciardiello
E. Van Cutsem
Harpreet Wasan
Takayuki Yoshino
Jayesh Desai
Janna Christy-Bittel
Rona Yaeger
Axel Grothey
J. Tabernero
Scott Kopetz
K. Maharry
Source :: Annals of Oncology. 31:S243
Publication Year :: 2020
Publisher :: Elsevier BV, 2020.

Subjects :: Oncology
medicine.medical_specialty
Cetuximab
biology
Colorectal cancer
business.industry
Binimetinib
Hematology
medicine.disease
chemistry.chemical_compound
Carcinoembryonic antigen
chemistry
Internal medicine
medicine
biology.protein
business
medicine.drug

Full Text Access

Tools